The Category 2 designation was not a finding that BPC-157 is dangerous per se, but rather that insufficient human safety data exists to justify its use in compounded medications without the oversight of the standard drug approval process
Published scientific literature has discussed BPC-157 and TB-500 in relation to peptide biology, molecular signaling pathways, protein interactions, extracellular matrix research, cellular communication models, and analytical peptide chemistry
Pregnant and lacating women were excluded in both datasets
Multi-dose vial design also matters
Why Minnesota Runners Are Especially At Risk Running puts massive stress on your feet
7-Day Support: Research support available via email, phone, or text, 7 days a week